Trial watch: targeting IL-17A shows broad promise in autoimmune diseases.
D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology* / Q000378:metabolism; D017322:Clinical Trials, Phase II as Topic / Q000379:methods* / Q000639:trends; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism
D020381:Interleukin-17